Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect.
- Update frequency
- every 7 days
- Average duration
- 49 minutes
- Episodes
- 270
- Years Active
- 2020 - 2025
Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.
We love to hear from our listeners. Send us a message.
On this week's episode, Atul Deshpande, Ph.D., CEO at Immediate Therapeutics, talks about partnering with American cities to conduct clinical tr…
Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.
We love to hear from our listeners. Send us a message.
On this week's episode, ex-handballer Vladimir Cmiljanovic, Ph.D., Founder and CEO at Swiss Rockets, talks about co-discovering bimiralisib with…
Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia
We love to hear from our listeners. Send us a message.
On this week's episode, Milan Kalawadia, CEO, North America, Dr. Reddy's Laboratories, and Arun Swaminathan, Ph.D., CEO, Coya Therapeutics discu…
How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak
We love to hear from our listeners. Send us a message.
On this week's episode, Bill Holodnak, Cofounder and CEO of Occam Global, a life sciences executive recruitment firm (and occasional investor), …
The Generalist Biotech CEO With Seekyo's Oury Chetboun
We love to hear from our listeners. Send us a message.
On this week's episode, Oury Chetboun, co-founder and CEO of Seekyo, a French biotech, talks about the range of experiences that prepared him to…
Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.
We love to hear from our listeners. Send us a message.
On this week's episode, Ebrahim Delpassand, M.D., founder, CEO, and chairman of the board at RadioMedix talks about his personal journey standin…
Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.
We love to hear from our listeners. Send us a message.
On this week's episode, Dr. Hernan Bazan, M.D., co-founder and CEO at New Orleans-based South Rampart Pharma, talks about building an ultra-lean…
The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics
We love to hear from our listeners. Send us a message.
On this week's episode, Roger Cone, Ph.D., Founder and Chair of the Scientific Advisory Board at Courage Therapeutics, talks about discovering o…
BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies
We love to hear from our listeners. Send us a message.
This week's episode is one from the road, recorded in front of a live audience in Boston's Seaport neighborhood during the BIO conference (speci…
How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Jennifer Hawks Bland, CEO of NewYorkBIO, shares insights on New York State's life sciences ec…
FDA Trials And Tribulations With Connect Biopharma's Barry Quart
We love to hear from our listeners. Send us a message.
On this week's episode, Barry Quart, CEO of Connect Biopharma, weighs in on the current state of engagement between drug developers and the FDA,…
Proactive Procurement Strategies For Biotech With Tom Wells
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Tom Wells, Director of Life Sciences at 4C Associates, reveals why -- and how -- smart procur…
The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson
We love to hear from our listeners. Send us a message.
On this week's episode, Thomas Levenson, MIT professor and author of So Very Small: How Humans Discovered The Microcosmos, Defeated Germs — And …
Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.
We love to hear from our listeners. Send us a message.
On this week's episode, Dr. Srinivas Rao, co-founder and CEO at atai Life Sciences, explains how his engineering background led him to the devel…
Biotech Angel Investing With Yaniv Sneor
We love to hear from our listeners. Send us a message.
On this week's episode, Yaniv Sneor, founder of the Mid Atlantic Bio Angels and CEO at Native State Therapeutics, explains how life science ange…
Leading A tRNA Startup With Alltrna's Michelle Werner
We love to hear from our listeners. Send us a message.
On this week's episode, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch…
Executing A Product Pivot With Vir Bio's Mark Eisner, MD
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Dr. Mark Eisner, EVP and Chief Medical Officer at Vir Bio, talks about the company's post-COV…
Commercializing RNAi Therapies With Alnylam's Tolga Tanguler
We love to hear from our listeners. Send us a message.
On today's episode, Tolga Tanguler, EVP and Chief Commercial Officer at Alnylam Pharmaceuticals, talks about commercializing RNAi therapies, how…
Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie
We love to hear from our listeners. Send us a message.
On today's episode I'm speaking with Brian Lortie, President and CEO of Uniquity Bio, about his "no jerk" policy and how his experience building…
The Implications Of China's Growing Biotech Industry With Allan Shaw
We love to hear from our listeners. Send us a message.
Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global inno…